An investigation of the problem of two-layered immunohistochemical staining in paraformaldehyde fixed sections

被引:22
作者
Torres, Eduardo M.
Meldrum, Alicia
Kirik, Deniz
Dunnett, Stephen B.
机构
[1] Univ Cardiff Wales, Sch Biosci, Cardiff CF10 3US, Wales
[2] Lund Univ, Wallenberg Neurosci Ctr, Lund, Sweden
基金
英国医学研究理事会;
关键词
fixation; immunohistochemistry; staining artefact; two-layer staining; paraformaldehyde;
D O I
10.1016/j.jneumeth.2006.05.016
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In sections of paraformaldehyde, fixed brain tissue, stained using immunohistochemical methods, the distribution of staining within the sections is not uniform. Whilst stained cells are seen at the top and bottom surfaces, the central thicknesses of the sections contain little or no immunoreactivity. This presents a major problem for quantification, as each section contains a population of cells that is not visualized by the staining method. Following extensive investigation of this phenomenon, we report that the failure of full thickness, immunohistochemical staining is not a failure of the immunohistochemical methodology per se, nor is it related directly to the thickness of the sections used. Rather, the problem lies in the chemistry of the tissue itself, and originates during fixation of the tissues using paraformaldehyde-based perfusion methods, which render the cell membranes impermeable to one or more components of the staining protocol. We show that this impermeability is affected by addition of membrane-disrupting agents to the fixative, and by a reduction of exposure to paraformaldehyde during fixation. The present investigation contributes to the development of new fixation protocols, optimised for use in both immunohistochemical methods and morphometric analyses. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:64 / 74
页数:11
相关论文
共 24 条
[1]  
Andersen BB, 1999, J MICROSC-OXFORD, V196, P69
[2]  
Bancroft J. D., 1990, THEORY PRACTICE HIST
[3]   Comparative evaluation of synaptophysin-based methods for quantification of synapses [J].
Calhoun, ME ;
Jucker, M ;
Martin, LJ ;
Thinakaran, G ;
Price, DL ;
Mouton, PR .
JOURNAL OF NEUROCYTOLOGY, 1996, 25 (12) :821-828
[4]   Dopaminergic neurons protected from degeneration by GDNF gene therapy [J].
ChoiLundberg, DL ;
Lin, Q ;
Chang, YN ;
Chiang, YL ;
Hay, CM ;
Mohajeri, H ;
Davidson, BL ;
Bohn, MC .
SCIENCE, 1997, 275 (5301) :838-841
[5]   Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation [J].
Deacon, T ;
Dinsmore, J ;
Costantini, LC ;
Ratliff, J ;
Isacson, O .
EXPERIMENTAL NEUROLOGY, 1998, 149 (01) :28-41
[6]  
Dèglon N, 2002, CURR TOP MICROBIOL, V261, P191
[7]   Tissue shrinkage and unbiased stereological estimation of particle number and size [J].
Dorph-Petersen, KA ;
Nyengaard, JR ;
Gundersen, HJG .
JOURNAL OF MICROSCOPY-OXFORD, 2001, 204 :232-246
[8]   Differential tissue shrinkage and compression in the z-axis:: implications for optical disector counting in vibratome-, plastic- and cryosections [J].
Gardella, D ;
Hatton, WJ ;
Rind, HB ;
Rosen, GD ;
von Bartheld, CS .
JOURNAL OF NEUROSCIENCE METHODS, 2003, 124 (01) :45-59
[9]   Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo [J].
Gerdes, CA ;
Castro, MG ;
Löwenstein, PR .
MOLECULAR THERAPY, 2000, 2 (04) :330-338
[10]  
HEMMINGS HC, 1986, J NEUROSCI, V6, P1469